Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-008663
Filing Date
2013-02-14
Accepted
2013-02-14 11:00:37
Documents
3
Period of Report
2013-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v335228_6k.htm 6-K 8146
2 EXHIBIT 99.1 v335228_ex99-1.htm EX-99.1 8497
3 GRAPHIC logo.jpg GRAPHIC 7478
  Complete submission text file 0001144204-13-008663.txt   27992
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 13607752
SIC: 2834 Pharmaceutical Preparations